CSS
AUGX

Cubist Systematic Strategies’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Cubist Systematic Strategies’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,820
Closed -$10.4K – 3628
2024
Q2 		$10.4K Sell
11,820
-68,323
-85% -$141K ﹤0.01% 2792
2024
Q1 		$328K Buy
80,143
+21,546
+37% +$96.4K ﹤0.01% 2839
2023
Q4 		$343K Buy
58,597
+37,347
+176% +$197K ﹤0.01% 2726
2023
Q3 		$109K Sell
21,250
-2,328
-10% -$10.9K ﹤0.01% 2924
2023
Q2 		$113K Buy
+23,578
New +$81.6K ﹤0.01% 2972

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Cubist Systematic Strategies's AUGX Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 11,820 shares — an estimated $10.4K sold.

Cubist Systematic Strategies first reported a position in AUGX in Q2 2023 and held it in 5 quarters. The position peaked at $343K in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,820 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $10.4K.
  • Cubist Systematic Strategies first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • Cubist Systematic Strategies's Augmedix, Inc. Common Stock position peaked at $343K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.